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mia/reperfusion injury. Since caspase-6 is involved in the degra-Cloning and expression of rat caspase-6 and its localization in
dation of nuclear matrix proteins and in activation of caspase-3,renal ischemia/reperfusion injury.
it may play an important role during renal ischemic injury.Background. Caspase-6 is an important member of the exe-
cutioner caspases in the caspase family of cell death proteases.
The executioner caspases are the major active caspases de-
tected in apoptotic cells and are generally considered to me- Caspases are a family of structurally related cysteinediate the execution of apoptosis by cleaving and inactivating
proteases that play a central role in the execution of apo-intracellular proteins. However, the complete characteriza-
ptosis [1–6]. On receiving a pro-apoptotic stimulus, thetion of mRNA and protein of caspase-6 in rat and its expres-
sion in normal kidney and in disease state has not been pre- caspases are proteolytically processed to the active forms
viously elucidated. from their normally synthesized inactive proenzymes. At
Methods. A rat kidney cortex gt10 cDNA library was least fourteen caspases encoded by distinct genes havescreened to isolate the full-length caspase-6 cDNA. The recom-
been cloned and sequenced to date in mammals [1, 7].binant caspase-6 protein was characterized by expression in
Caspase-2, -8, -9, and -10 have large prodomains and initi-bacteria and by transient transfection in mammalian cells. The
expression in various tissues was analyzed by Northern blot, ate the activation of downstream caspases. Caspase-3, -6,
and localization in normal and ischemic kidney was performed and -7 with smaller domains are identified as effecter or
by immunohistochemistry. executioner caspases [1–3, 7]. The executioner caspasesResults. The predicted amino acid sequence of rat caspase-6
are the major active caspases detected in apoptotic cells,contains 277 amino acids, with two potential glycosylation sites,
and are widely regarded to mediate the execution ofan integrin binding site (KGD), the caspase active site penta-
peptide QACRG and the caspase family signature, HX2-4(S,C) apoptosis by cleaving and inactivating intracellular pro-
X4(L,I,V,M,F)2(S,T)HG (HVDADCFVCVFLSHG). Rat cas- teins that are essential for cell survival and proliferation
pase-6 is unique among known caspases by possessing a relatively [1–3, 8]. The specificity of downstream executioner cas-long 5 untranslational region. Among various tissues tested, cas-
pases to cleave cellular proteins is unique because ofpase-6 was expressed in varying levels in kidney, liver, spleen,
their different primary sequences and different recog-heart, muscle, testis, and lung. Bacterial expression of recombi-
nant rat caspase-6 resulted in production of both of the pro- nition sites on the target proteins. For example, follow-
form and active form of the enzyme suggesting autoactivation. ing activation, caspase-3 primarily recognizes DEVD or
Transient overexpression of rat caspase-6 in COS-1 cells in- DMQD tetrapeptide sequences whereas caspase-6 rec-
duced DNA fragmentation, a hallmark of apoptosis. We also
ognizes the VEID tetrapeptide sequence for cleavageexamined the localization and expression of caspase-6 by im-
after the aspartate residue on the target proteins [1–3, 6].munohistochemistry in kidneys subjected to 40 minutes of isch-
Multiple pathways can result in activation of executioneremia followed by 24 hours of reperfusion injury. Normal kidney
showed mostly cytoplasmic and some nuclear staining of the caspases depending on the nature of the death-inducing
tubules. Kidneys 24 hours after 40 minutes of ischemia showed stimulus. At present, there are two relatively well-charac-
more intense and diffused cytoplasmic staining with prominent terized cell death pathways that result in the activation ofnuclear staining, indicating increased expression and transloca-
the downstream executioner caspase-3. One is receptor-tion from the cytoplasm to the nuclei. The staining in glomeruli
mediated [9] and the other is mitochondrial-dependentwas negative in both normal and ischemic kidney.
Conclusions. These studies demonstrate cloning, expression [10]. The receptor-dependent pathway is initiated by acti-
and characterization of the full-length rat caspase-6 and its vation of cell death receptors (Fas and tumor necrosis
localization in normal kidneys and kidneys subjected to ische- factor ) leading to activation of procaspase-8, which in
turn cleaves and activates procaspases-3. The mitochon-
drial-dependent pathway is triggered by cytochrome c re-Key words: rat kidney, acute renal failure, executioner caspases, cell
death, apoptosis mediators, renal injury. lease from the mitochondria. The cytosolic cytochrome c
recruits procaspase-9, Apaf-1, and dATP and promotes 2002 by the International Society of Nephrology
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caspase-9 activation. Activated caspase-9 then cleaves 9600 with the following conditions: 94C for 60 seconds
followed by 94C for 5 seconds, 50C for 30 seconds;and activates procaspase-3 to its active form [1, 9, 10].
Thus, extensive studies have been done on caspase-3 but 68C for two minutes (30 cycles), and a final extension
at 68C for seven minutes. The amplified products werevery little information is available on the executioner
caspase, caspase-6, in the apoptotic pathway. resolved by gel electrophoresis on 1% agarose (FMC
BioProducts, Rockland, ME, USA) and visualized byMany studies have documented the occurrence of apo-
ptosis during renal ischemia/reperfusion injury and other ethidium bromide staining. The appropriate sized band
was excised from the gel, purified, and subcloned intorenal diseases [11–15]. Since the executioner caspases are
key intracellular mediators of apoptosis, their activation a pGEMT vector (Promega, Madison, WI, USA). The
cloned cDNA was sequenced using vector primer sites,may play an important role in renal injury. To examine
the specific role of executioner caspases in renal injury T7 and SP6.
it is essential to know if these caspases are transcribed
Cloning of rat caspase-6in the kidney. We have recently shown that rat kidney
transcribes the genes for caspase-1, -2, -3, -6, -7, -8, and The cloned cDNA fragment was excised out from the
pGEMTvector, radio-labeled by random priming-9 [16], indicating that all of the executioner caspases
are expressed in the kidney. However, the complete (Amersham Life Science, Arlington Heights, IL, USA)
with [-32P] dCTP, purified by chromatography on Nuc-characterization of mRNA and proteins of most of these
caspases in rat kidney remain to be accomplished. At Trap Push Columns (Stratagene, La Jolla, CA, USA),
and used to screen a rat kidney cortex gt10 cDNApresent, complete identification and characterization of
mRNAs and proteins of only three rat caspases, cas- library (Clontech Inc., Palo Alto, CA, USA). About 5 
105 plaques were screened using standard protocols [20].pase-1 [17], caspase-2 [18] and caspase-3 [19], have been
reported. To further examine the specific role of the After four cycles of plaque purification six positive clones
were purified and the cDNA inserts were excised usingindividual executioner caspases in renal injury, we fo-
cused our present study on caspase-6. This study reports EcoR1 restriction enzyme. The excised cDNAs were gel
purified (Qiagen Inc, Valencia, CA, USA) and subclonedthe cloning and sequencing of the full-length cDNA of
rat caspase-6, and characterization of the recombinant into the vector p ZERO (Invitrogen Inc, Carlsbad, CA,
USA).protein expressed in bacteria and by transient transfec-
tion in mammalian cells. We also examined the expres-
Sequencingsion of caspase-6 in various tissues and its localization
by immunohistochemistry in normal kidney as well as Sequencing was performed on both strands using T7
and SP6 primers, and thereafter walking along with gene-in kidneys subjected to ischemia/reperfusion injury.
specific primers using the dideoxy DNA cycle sequencing
system (Gibco BRL, Gaithersburg, MD, USA) and con-
METHODS
firmed by sequencing on an automated DNA sequencer
RT-PCR (Applied Biosystems Inc., Foster City, CA, USA). The
sequence for caspase-6 reported in this article was depos-Poly A RNA was isolated from normal rat kidney
and reverse transcription-polymerase chain reaction ited in the GenBank database (accession numbers
AF025670, NM031775).(RT-PCR) was performed as described previously [16].
Briefly, 1 g of poly A was reverse-transcribed using
Northern blot analysisan oligo (dT) primer and Moloney murine leukemia virus
reverse transcriptase (Perkin-Elmer, Branchburg, NJ, Northern blot analysis was performed as previously
described [20]. In brief, 25 g of total RNA isolatedUSA). The resulting reverse transcription product was
used as a template for PCR using sense and antisense from different adult rat organs was electrophoresed un-
der denaturing condition on a 1.2% agarose gel andprimers based on the human caspase-6 coding sequence
(GenBank accession #U20537). The sequences of prim- blotted to Immobilon N nylon membrane (Millipore,
Bedford, MA, USA). The membrane was baked underers used and their locations in the human caspase-6 cod-
ing sequence are: sense, CTAATCTTCAATCACGA vacuum for one hour and hybridized with 32P-labeled
full-length caspase-6 cDNA as probe under standardGAGGTTC (221-243) and antisense, CTCACACAA
ATCTTGAA TGTACCA (780-757) (National Biosci- condition [20]. After washing, the membrane was sub-
jected to autoradiography at 70C to detect mRNAence, Plymouth, MA, USA). The criteria to use these
primers were described in our previous study [16]. At- signals.
tempts to amplify rat caspase-6 using degenerate primers
In vitro translationdesigned from the N-terminal initiating domain or from
the prodomain of human caspase-6 were unsuccessful. The full-length rat caspase-6 cDNA was subcloned
into the vector pZERO. The recombinant plasmid wasPCR was performed in a Perkin-Elmer Thermocycler
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then linearized on the 3 end of the insert using the NotI of these tags. The resultant plasmid was transformed
into the E. coli strain BL21 (FompTrB mB ). The trans-restriction enzyme. In vitro translation was performed
using the TNT T7-coupled reticulocyte lysate system formed bacteria were cultured in the presence of 1
mmol/L isopropylthiogalactoside (IPTG; Pharmacia-(Promega Inc.) and [35S]-methionine (Amersham Corp.)
as per the manufacturer’s recommendation. In brief, LLB, Uppsala, Sweden) for three hours. After optimal
induction, the bacterial culture was centrifuged and pel-linear plasmid (1 g), amino acid mix minus methio-
nine (1 mmol/L), ribonuclease inhibitor, [35S]-methionine lets were suspended in ice-cold buffer containing 20
mmol/L HEPES, pH 7.8, 5 mmol/L imidazole, 0.5 mol/L(1000 Ci/mmol), and T7 polymerase were added to a 50
L reaction mix and incubated at 30C for two hours. The NaCl, and protease inhibitors (10 g/mL aprotinin, 1
g/mL antipain, 1g/mL pepstatin, 17.5 g/mL benzam-reaction products were analyzed on 12% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). idine), and homogenized. The supernatants were first
purified on columns containing nickel bound resin (5
Expression plasmid and transient transfection mL) using the His-Bind buffer kit supplied by Novagen.
The proteins eluted from the columns were dialyzedThe full-length caspase-6 cDNA was subcloned in the
mammalian expression vector pcDNA3.1 (Invitrogen extensively in 20 mmol/L HEPES, pH 7.8,containing pro-
tease inhibitors and further purified on a Mono Q columnInc.) downstream of the cytomegalovirus promoter/en-
hancer. Transfection was carried out with Lipofectamine by applying a linear gradient of 0 to 0.5 mol/L NaCl in
20 mmol/L Tris-HCl buffer, pH 7.4, using an fast protein(Gibco BRL) according to the manufacturer’s recom-
mendation. In brief, 2.0  105 COS-1 cells were tran- liquid chromatography (FPLC) system. Purification of
rat caspase-6 in both proenzyme forms and active formssiently transfected in 2 mL of serum free medium with a
mixture of 1 g of pCMV 	-galactosidase plus 6 g of (P10 and P20 subunits) are shown in Figure 6.
test plasmid. Control cells were transfected with empty
Determination of caspase-6 activityvector. After five hours, 4 mL of serum containing growth
medium was added. Forty-eight hours post-transfection, Bacterial cell pellets containing recombinant caspase-6
were lysed with 20 mmol/L HEPES, pH 7.5, containingcells were washed twice with 1 phosphate-buffered sa-
line (PBS), scraped, and processed for 	-galactosidase 10% sucrose, 0.1% CHAPS, 2 mmol/L dithiothreitol
(DTT), 0.1% NP40, 1 mmol/L ethylenediaminetetraace-assay (according to the manufacturer’s recommenda-
tion) as well as for DNA damage as previously described tic acid (EDTA), 1 mmol/L phenylmethylsulfonyl fluo-
ride (PMSF), 1 g/mL leupeptin, and 1 g/mL pepstatinin our studies [21].
A at 4C. The supernatants obtained after centrifugation
Genomic DNA extraction and electrophoresis were used to determine the enzyme activity. The activity
of caspase-6 was determined by fluorometric assay usingTransfected cells were scraped into medium 48 hours
post-transfection and all cells, including the floating cells, the substrate VEID-AMC that is specifically cleaved by
the enzyme at the Asp residue to release the fluorescentwere collected. Genomic DNA was isolated by protein-
ase K digestion, phenol-chloroform extraction, and etha- leaving group amino-4-methyl coumarin (AMC) [16, 22].
The enzyme extracts containing 50 g protein were incu-nol precipitation as described [21]. The DNA samples
were analyzed by electrophoresis on 1.8% agarose gel bated with 100 mmol/L HEPES, pH 7.4, containing 10%
sucrose, 0.1% CHAPS, 10 mM DTT, and 50 mol/L ofand DNA was observed by ethidium bromide staining
of the gel. caspase substrate in a total reaction volume of 0.25 mL.
The reaction mixture was incubated for 60 minutes at
Expression of recombinant caspase-6 in bacteria 30C. At the end of the incubation, the liberated fluores-
cent group, AMC, was determined using a fluorescentThe coding sequence of rat caspase-6 was PCR ampli-
fied using 5 and 3 PCR primers (sense: GGTAAGA Spectrofluorometer (Perkin Elmer) with an excitation
wavelength of 380 nm and an emission wavelength ofATTCATGACGGAGACAGATGGC and antisense:
TTGGAGCGGCCG CCTACTTACTAGGTTTGGG) 460 nm [22]. AMC was used as a standard. Based on the
standard curve made with fluorescence readings withcontaining Nde and XhoI custom restriction sites, gel
purified, and subcloned in-frame into the NdeI and XhoI free AMC, the data for caspase activity are expressed
as nanomoles of AMC liberated when 50 g of proteinsites of the bacterial expression vector pET-21a () (No-
vagen). This subcloning placed the rat caspase-6 se- extract was incubated with 50 mol/L of substrate for
60 minutes at 30C.quence under the control of the inducible bacteriophage
T7-promoter and introduced an NH2-terminal polyhis-
Ischemia-reperfusion modeltidine tag (6 histidines) and S-tag for purification on a
nickel-chelating column and for identification by West- Adult male Sprague-Dawley rats used in the present
study were subjected to 40 minutes of ischemia by occlud-ern blot using s-tag antibody, respectively. An entero-
kinase cleavage site also was included to allow removal ing renal pedicles with smooth vascular clamps as pre-
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viously described [23] and then allowed to recover for signed from the corresponding human sequences. Our
24 hours. Each group consisted of six rats. Blood samples attempts to obtain full-length cDNA by RT-PCR were
were collected for creatinine and urea nitrogen determi- unsuccessful. However, we were able to amplify a 559-bp
nation. Animals were anesthetized before tissue harvest- cDNA fragment by RT-PCR using primers based on the
ing. Rats were perfused through the left ventricle with conserved internal sequences of human caspase-6. The
warm Hanks’ balanced salt solution (HBSS). Kidney amplified cDNA fragment obtained by RT-PCR was gel
tissues were fixed in formalin for histology and immuno- purified, and subcloned into the vector pGEMT and
histochemistry. The control group consisted of rats un- sequenced using vector primer sites. Two out of five
dergoing surgical exposure of kidneys without clamping clones sequenced were found to be identical and showed
the renal pedicles. significant homology to the human caspase-6 alpha gene
(we tentatively called this fragment the rat caspase-6
Immunohistochemistry cDNA fragment). The remaining cDNA fragments
Representative renal sections (4 to 5 m thick) of showed no homology to the caspases and were not pur-
formalin-fixed paraffin-embedded tissues of control and sued further.
ischemic kidney were used. Sections were mounted on We screened a normal rat kidney gt10 cDNA library
frosted micro slides and the paraffin-embedded sections using the subcloned rat caspase-6 cDNA fragment as a
were deparaffinized in xylene and re-hydrated through probe to obtain the full-length cDNA. A total of 5 
a graded series of alcohol (100 to 0%). Tissue sections 105 plaques were screened and several clones were puri-
were rinsed in PBS and endogenous peroxidase was inac- fied after four rounds of screening. Four clones (clone
tivated by incubations with 0.3% H2O2 in methanol. The 1: 1.2 kb; clone 2: 1.5 kb; clone 3: 1.8 kb and clone 4:
slides were extensively washed with PBS and preincu- 2.2 kb) were sequenced using vector primer sites and
bated with 5% bovine serum albumin (BSA) in PBS for thereafter walking along with primers. Sequencing re-
60 minutes to block nonspecific reaction with the antise- vealed that clone 2 contained a total of 1446 nucleotides
rum. Tissue sections were rinsed in PBS, and then incu- and represents the full-length rat caspase-6 cDNA. It
bated with anti-caspase-6 antibody (1:200; Cell Signaling contained the entire 559 bp sequence of the probe, ini-
Technology, Inc., Beverly, MA, USA) at 37C for two tiating methionine, stop codon, and poly adenylation
hours, washed in PBS and then incubated with horserad- signal (Fig. 1). Clone 1 was identical to clone 2 but was
ish peroxidase-conjugated-goat anti-rabbit IgG for an incomplete. Although clones 3 and 4 did contain the
hour. After washing with PBS, the sections were devel- entire sequence of clone 2, the sequence was interrupted
oped with DAB and H2O2. For negative control, primary with small stretches of nucleotide sequences of unknownantibody was omitted and normal rabbit serum was used
homology suggesting they represented the possibility ofat the same dilution.
incompletely processed pre mRNAs, thus these clones
were not pursued further.Preparation of nuclear and cytosolic fractions
The open reading frame (ORF) of clone 2 encodesNuclei from rat kidney cortex were isolated by homog-
277 amino acids (Fig. 1), which is relatively smaller thanenization followed by a sucrose gradient as previously
that reported for human caspase-6. In vitro translationdescribed [24]. In brief, nuclei were isolated from minced
of clone 2 using TNT T7 coupled reticulocyte lysatekidney cortex by homogenization at 0C in buffer A
system resulted in the both proform and the active sub-(20 mmol/L Hepes-NaOH, pH 7.4, 5 mmol/L MgCl2,
units (Fig. 2). Formation of smaller subunits from the0.2 mmol/L EGTA, 3 mmol/L 2-mercaptoethanol, 0.1
larger precursor represents the processing to form themmol/L PMSF, 1g/mL leupeptin, 1g/mL antipain)
active enzyme [2–5]. In comparison, rat caspase-3 trans-containing 0.93 mol/L sucrose. The filtered homogenate
lation to the proform and the active subunits is alsowas centrifuged over a cushion of 1.61 mol/L sucrose in
shown. The published full-length cDNA for mousebuffer A at 20,000  g at 4C for 20 minutes. The pellet
caspase-6 and its initiating codon [26] corresponds to thewas collected as a nuclear fraction and supernatant above
initiating codon of the rat caspase-6 cDNA suggestingthe sucrose cushion was further centrifuged at 100,000 
that this ATG site is conserved in rodents. To furtherg for 60 minutes, and the resulting supernatant was used
ensure that the cloned cDNA is in fact full-length, weas the cytosolic fraction. The nuclear pellets were washed
performed RACE using extreme 5 end of the rat cas-once in 0.25 mol/L sucrose in buffer A and resuspended
pase-6 as primer and obtained the same cDNA sequencein 0.6 mol/L NaCl in buffer A containing 10% glycerol.
as in the cloned cDNA obtained from library screening.
The initiating codon ATG in the cloned cDNA follows
RESULTS the KOZAK rule and is flanked by purine (A) at 3
Isolation and sequencing of rat caspase-6 and4 position [25]. In addition, an in-frame stop codon
TAA (bp 233–235) is preceded by the initiating codonTo obtain the full-length cDNA for rat caspase-6, we
first performed RT-PCR using degenerate primers de- ATG in the cloned cDNA, indicating that the initiation
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Fig. 1. Full-length sequence of rat caspase-6. Features in bold include
the start and stop codon, putative aspartic acid cleavage sites, potential
glycosylation sites (NVTQ, NGSW), and a potential integrin binding
site (KGD). The linker region is underlined. The active site is in italic
and underlined.
Fig. 2. In vitro translation of the full-length cDNA of rat caspase-6. In
vitro translation was performed using the TNT T7-coupled reticulocyte
lysate system (Promega Inc.) and [35S]-methionine (Amersham Corp.)
of caspase-6 expression should begin at this ATG site as per the manufacturer’s recommendation. The reaction products were
analyzed on 12% SDS-PAGE followed by autoradiography. Translation(bp 239–243). Thus, the occurrence of in-frame stop co-
products of caspase-6 and caspase-3 are shown.don further confirms the site of initiation at the ATG
site at bp 239–243.
The 5-UTR in rat caspase-6 is unexpectedly longer
than that reported for other species including human His-104), and those known to form the P1 carboxylate
binding pocket (Arg-47, Gln-144, Arg-200 and Ser-206)and mouse. On the other hand, the 3-UTR is shorter
than in human caspase-6. Like mouse caspase-6, the loca- were also conserved (Fig. 3). The location of aspartic
acids at positions 16, 162 and 173 suggest that this mole-tion of the initiating methionine in rat caspase-6 corre-
sponded with the second methionine (19th amino acid) cule is produced as a proenzyme since subunits of p18
and p11 are produced after aspartic acid cleavage. Theof human caspase-6 (Fig. 3). Blast analysis of total nucle-
otide sequences revealed 69% identity with human phylogenetic tree analysis showed a tight grouping with
other caspase-6 genes. Like the mouse gene, the prodo-caspase-6, however, GAP analysis of the ORF sequence
revealed highest 84% homology at the nucleotide level main in rat is relatively short for a caspase-6 gene, being
just five amino acids in length, compared to human,and 87.7% homology at the amino acid level with the
human caspase 6, and 40 to 50% identity to the other chicken and trout.
known caspases. The predicted amino acid sequence of
Northern analysis and tissue distributionrat caspase-6 showed two potential glycosylation sites, an
integrin binding site (KGD), the conserved pentapeptide Northern analysis of caspase-6 showed a single mRNA
transcript corresponding to a size of approximately 1.6 kb.QACRG sequence of the active site, and the caspase
family signature HX2-4(S,C)X4(L,I,V,M,F)2(S,T)HG (that To determine the tissue distribution of rat caspase-6,
we performed Northern blot analysis using poly Ais, HVDADCFVCVFLSHG) where X can be any amino
acid. Amino acids involved in catalysis (Cys-146 and RNA from various rat tissues. The results indicated that
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Fig. 4. Tissue distribution of rat caspase-6 mRNA. Total RNA from
each tissue was isolated as described in the text. A total of 25 g total
RNAs from various tissues of an adult rat were analyzed by Northern
blot analysis. The positions of 18S and 28S rRNAs are shown as indi-
cated.
the cloned rat caspase-6, we transiently transfected the
full-length cDNA in COS-1 cells. Transfection efficiency
was determined by 	-gal staining and also by Northern
blot analysis for caspase-6 (data not shown). Analysis
of genomic DNA from transfected cells showed 200-bp
laddering, indicating DNA fragmentation, a hallmark of
apoptosis, whereas no laddering was observed in un-
transfected control cells (Fig. 5).
Expression of rat caspase-6 in bacteria and
determination of its activity
To further characterize the cloned cDNA, the cod-
ing sequence was expressed in E. coli as a recombinant
protein. The caspase-6 protein was expressed as a pro-
enzyme as well as activated molecule indicating auto-
activation (Fig. 6). The activity of caspase-6 also was
confirmed by activity assay using the VEID-AMC sub-
strate (data not shown). This activity increased with in-
creasing periods of bacterial induction with IPTG. TheFig. 3. Alignment of the predicted rat caspase-6 amino acid sequence
recombinant protein was purified on nickel-columns us-with other known caspase-6 sequences. Identical and similar residues
(*) identified by the GELLYFISH program are indicated. The active ing the 3 his-tag (Fig. 6). The in vitro expression of
pentapeptide site and caspase family signature are boxed. Residues cloned cDNA in bacteria also provided biologically ac-involved in the P1 carboxylic binding pocket are in bold, the propiece
tive protein, as demonstrated by the activity assay of theis in italics, and residues involved in catalysis are in bold and indicated
with an arrow. recombinant enzyme (caspase activity in control; empty
vector) in homogenate (0.02 
 0.01 nmol), and in ex-
pressed (vector containing the coding sequence) homog-caspase-6 is expressed to varying levels within different
enate (8
 0.6 nmol) where both the pro-form and activetissues including in kidney, liver, spleen, heart, muscle,
subunits of caspase-6 were generated (Fig. 6).testis, and lung (Fig. 4), with the highest expression in
heart, lung, kidney, and muscle.
Localization and nuclear translocation
Overexpression of rat caspase-6 induces apoptosis During apoptosis caspases have been shown to disas-
semble a cell by cleaving a set of proteins and translocat-When overexpressed caspases induce DNA fragmen-
tation and apoptosis of host cells. In order to characterize ing into nucleus. Further, caspase-6 is involved in the
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Fig. 6. SDS-gel electrophoresis of the rat recombinant caspase-6 ex-
pressed in bacteria. The recombinant plasmid, pET-21a () containing
coding sequence of ratcaspase-6 and His–tag was transformed into the
E. coli strain BL21 (FompTrB mB ). Following induction with IPTG
the bacteria were harvested and following lysis the supernatants were
purified on columns containing nickel bound resin. Lanes are: A, molec-
ular weight standards; B, homogenate from uninduced bacteria; C,
homogenate from 1 mmol/L IPTG-induced bacteria; D, recombinant
caspase-6 purified on nickel column followed by purification on Mono
Q column; E, proenzyme; F, p20 subunit; G, p10 subunit. The proform
and subunits were first separated on preparative gel electrophoresis.
to a 46 kD lamin A fragment during ischemic injury
(Fig. 9). This cleavage is attributed to the action of
caspase-6 since this caspase not other caspases has beenFig. 5. DNA fragmentation by overexpression of rat caspase-6 in
COS-1 cells. Fragmented DNA was isolated from control and caspase-6 shown to cleave lamin A [27, 28].
overexpressing cells and subjected to 1% agarose gel electrophoresis.
The DNA was visualized by UV fluorescence after staining with ethid-
ium bromide. Lanes are: (A) molecular size markers, (B) control cells DISCUSSIONtransfected with empty vector, and (C) caspase-6 overexpressing cells.
Our studies demonstrate the cloning, sequencing, and
characterization of the rat caspase-6 cDNA and its ex-
pression in the kidney. The cloned cDNA shows highest
degradation of nuclear matrix proteins and in caspase-3
homology with the known caspase-6 genes and closeactivation. Therefore, we examined the expression and
homology with other executioner caspases. Like otherlocalization of caspase-6 by immunohistochemistry in
caspases, the rat caspase-6 contains the caspase familynormal kidney as well as kidneys subjected to 40 minutes
signature and the conserved active site pentapeptideof ischemia followed by 24 hours of reperfusion injury.
QACRG required for proteolytic activity. In commonNormal kidney showed mostly cytoplasmic and some
with executioner caspases and caspase-14, caspase-6 hasnuclear staining of the proximal tubules. Kidneys 24
a relatively short prodomain [29], and a linker regionhours after 40 minutes of ischemia showed more intense
where conserved Asp residues allow cleavage by otherand diffused cytoplasmic staining, with nuclear staining
caspases to release the active heterodimer. Within theprimarily in the tubular segments of the cortex, indicating
prodomain, rat caspase-6 shows close homology at theincreased expression and nuclear translocation (Fig. 7).
amino acid level to the mouse caspase-6 but rela-Only occasional staining was observed in the distal tu-
tively poor homology to the human, chicken and troutbules within the cortex. The staining in the glomeruli
caspase-6. Among the three predicted cleavage sites forwas negative in both normal and ischemic kidney. The
the human caspase-6 prodomain [30] that occur atcytosolic and nuclear fractions from the control and isch-
Asp23-Ala24, Asp32-Pro-33, and Asp40-His 40, only theemic kidneys also were examined for the expression of
last site is conserved within the rat sequence. The ratcaspase-6 by Western blot analysis. As shown in Figure 8,
caspase-6 is unique among known caspases in that itthe increased expression of the cytosolic and nuclear
possesses a relatively long 5-UTR. On long 5-UTRscaspase-6 in ischemic kidney corresponds very well to
Cap-dependent ribosomal scanning has been shown tothe immunoperoxidase staining data. Nuclear fractions
be severely hampered [30, 31]. Long 5-UTRs are oftenisolated from the control and ischemic kidneys also were
found in mRNAs encoding regulatory proteins likeexamined for the cleavage of nuclear matrix protein,
lamin A. Our data demonstrate that lamin A is cleaved proto-oncogenes, growth factors and their receptors, and
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Fig. 7. Immunoperoxidase staining of caspase-6 in renal ischemia/reperfusion injury. Immunohistochemical localization was performed as described
in the text. (A) Tissue sections from normal rat kidney show mostly cytoplasmic and some nuclear staining of the proximal tubules. (B and C )
Representative tissue sections from kidneys 24 hours after 40 minutes of ischemia show more intense and diffused cytoplasmic staining with
prominent nuclear staining primarily in the proximal tubular segments of the cortex. Glomeruli show negative staining for caspase-6 in both normal
and ischemic kidneys.
Fig. 8. Distribution of caspase-6 in cytosolic and nuclear fractions of
ischemic kidney. Cytosolic (C) and nuclear (N) fractions were isolated
from control and ischemic kidneys as described in the Methods section,
and were subjected to Western blot analysis [16] using anti-caspase-6
antibody (1:1000, Cell Signaling Technology).
homeodomain proteins and are suspected to provide a Fig. 9. Cleavage of lamin A in ischemic kidney. Nuclear fractions from
control (A) and ischemic (B) kidneys were examined by Western blotregulatory mechanism [31, 32]. However, the mecha-
analysis [16] using anti-lamin A antibody (Santa Cruz Biotechnology,nisms involved in 5-UTR-mediated control are not well Inc.).
understood. It is possible that the long 5-UTR of rat
caspase-6 is involved in its translational regulation. As
with all caspases, the rat gene shows conservation of
residues known to form the P1 carboxylate-binding [28, 33]. Caspase-6, but not caspase-3, is activated during
pocket reflecting the absolute requirement for an Asp neuronal apoptosis and is responsible for the processing
at position P1 for substrate cleavage [33]. Residues that of amyloid precursor protein (APP) to generate in-
form the P2-P4 binding pocket are less conserved be- creased production of Alzheimer’s amyloid beta peptide
tween caspases, accounting for differences in substrate
(A 	) [34–36]. However, in sharp contrast, much infor-
specificity.
mation is available on the protein targets for caspase-3Although caspase-6 is an important member of the
and its role has been extensively studied. Caspase-3 hasexecutioner caspases, the steps involved in its activation
been reported to degrade many key structural and regu-and its relative contribution in the cell death pathway
latory proteins including DNA repair enzymes [1, 37–39],are not as well understood as for caspase-3. The identity
ICAD (inhibitor of caspase-activated DNase) or DNAof some target cellular proteins for caspase-6 in response
fragmentation factor [40, 41], nuclear structural proteinsto various apoptotic stimuli has recently been reported.
[1, 42, 43], cytoskeleton proteins [1, 33, 44], transcriptionThe nuclear matrix protein, lamin A, is the only protein
exclusively targeted and cleaved by the activated caspase-6 factors [1, 45–48], and regulatory proteins including the
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